Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review
Top Cited Papers
- 15 November 2006
- journal article
- review article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 20 (6) , 563-576
- https://doi.org/10.1111/j.1472-8206.2006.00447.x
Abstract
Gadolinium‐based contrast agents (CAs) are widely used to enhance the contrast of images in magnetic resonance imaging procedures. Two categories of gadolinium chelates exist: the macrocyclic molecules where Gd3+ is caged in the pre‐organized cavity of the ligand and the linear molecules. Gadolinium chelates differ in their thermodynamic stability constants and in their kinetic stability. In general, macrocyclic chelates such as Gd‐DOTA or Gd‐HP‐DO3A are more stable than linear molecules. Even among linear agents, differences can be found. There is increasing evidence that transmetallation can be found in vivo, in the case of certain CAs (especially linear chelates), with body cations such as zinc, calcium or iron. Furthermore, analytical interference with colorimetric determination of calcium has been clinically evidenced with two linear chelates, Gd‐DTPA‐BMA and Gd‐DTPA‐BMEA. Clinical cases of spurious hypocalcaemia have been reported with these molecules. Such interference with some colorimetric assays for calcium is clinically relevant in that it can lead to unnecessary and potentially harmful treatment for hypocalcaemia.Keywords
This publication has 63 references indexed in Scilit:
- Comparison of Gd(DTPA-BMA) (Omniscan) Versus Gd(HP-DO3A) (ProHance) Relative to Gadolinium Retention in Human Bone Tissue by Inductively Coupled Plasma Mass SpectroscopyInvestigative Radiology, 2006
- Spurious Hypocalcemia After Gadodiamide AdministrationMayo Clinic Proceedings, 2005
- Artifactual hypocalcaemia after intravenous administration of gadodiamide (Omniscan®)Nephrology Dialysis Transplantation, 2005
- Pseudohypocalcemia after magnetic resonance imaging with gadolinium in patients with cirrhosisLiver Transplantation, 2004
- Safety assessment of gadoversetamide (OptiMARK®) administered by power injectorJournal of Magnetic Resonance Imaging, 2003
- Exploring the structure and function of zinc metallopeptidases: old enzymes and new discoveriesBiochemical Society Transactions, 2003
- Human In Vivo Comparative Study of Zinc and Copper Transmetallation After Administration of Magnetic Resonance Imaging Contrast AgentsInvestigative Radiology, 1996
- Biodistribution of Radiolabeled, Formulated Gadopentetate, Gadoteridol, Gadoterate, and Gadodiamide in Mice and RatsInvestigative Radiology, 1995
- Preclinical Safety Assessment and Pharmacokinetics of Gadodiamide Injection, a New Magnetic Resonance Imaging Contrast AgentInvestigative Radiology, 1993
- A Phase I Clinical Trial with Gadodiamide Injection, a Nonionic Magnetic Resonance Imaging Enhancement AgentInvestigative Radiology, 1991